Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.

Blood
Ching-Hon PuiTotal Therapy Study XIIIB at St Jude Children's Research Hospital

Abstract

St Jude Total Therapy Study XIIIB for childhood acute lymphoblastic leukemia (ALL) incorporated more stringent risk classification, early intensification of intrathecal chemotherapy, reinduction treatment, and the addition of dexamethasone to postremission therapy to increase the proportion of event-free survivors without jeopardizing their quality of life. Cranial irradiation was reserved for the 12% of patients who had T-cell ALL and a presenting leukocyte count of 100 x 10(9)/L or more, or CNS-3 (5 or more leukocytes/microL with identifiable blast cells in an atraumatic sample or the presence of cranial nerve palsy) status. Among the 247 consecutive patients enrolled in the study, 117 were classified as having lower-risk leukemia and received mainly antimetabolite-based continuation therapy; the 130 cases with higher-risk leukemia received more intensive continuation chemotherapy with multiple drug pairs administered in weekly rotation. The 5-year event-free survival estimate was 80.8% +/- 2.6% (SE); the 8-year rate was 78.6% +/- 5.8%. The 5-year cumulative risk of an isolated central nervous system (CNS) relapse was 1.7% +/- 0.8%, and that of isolated plus combined CNS relapse was 3.0% +/- 1.1%. The 5-year cumulative risks ...Continue Reading

References

Aug 27, 1998·The New England Journal of Medicine·C H Pui, W E Evans
Jun 10, 2000·British Journal of Haematology·C H Pui, M V Relling
Jun 23, 2000·Journal of Pediatric Hematology/oncology·D P WaberS E Sallan
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·J G BlancoM V Relling
Oct 22, 2002·JAMA : the Journal of the American Medical Association·Scott C HowardChing-Hon Pui
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ching-Hon Pui
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Britta BürgerMartin Schrappe
Apr 30, 2003·Statistics in Medicine·Jonathan P MylesAnthony Howell
Jun 6, 2003·British Journal of Haematology·Dario Campana
Aug 15, 2003·The New England Journal of Medicine·Ching-Hon PuiMelissa M Hudson
Oct 16, 2003·JAMA : the Journal of the American Medical Association·Ching-Hon PuiWilliam E Evans
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing

❮ Previous
Next ❯

Citations

Jan 30, 2009·JAMA : the Journal of the American Medical Association·Jun J YangMary V Relling
Dec 4, 2008·Annals of Hematology·Yok-Lam KwongJoyce C W Chan
Apr 6, 2013·Annals of Hematology·Sang Min LeeUNKNOWN Korean Society of Hematology Adult ALL working party
Jul 1, 2008·Current Hematologic Malignancy Reports·Elly V Barry, Lewis B Silverman
Apr 25, 2012·Current Hematologic Malignancy Reports·Ilaria IacobucciGiovanni Martinelli
Apr 13, 2011·Current Treatment Options in Neurology·Seema Nagpal, Lawrence Recht
Feb 9, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Isabel BadellUNKNOWN SHOP Leukemia and Lymphoma Studies Committee (Spanish Societies of Pediatric Hematology and Pediatric Oncology)
May 22, 2010·International Journal of Hematology·Samart PakakasamaSomjai Kanjanapongkul
Dec 13, 2007·Nature Clinical Practice. Oncology·Ching-Hon PuiMary V Relling
Aug 18, 2009·Nature Genetics·Lisa R TreviñoMary V Relling
Feb 8, 2011·Nature Genetics·Jun J YangMary V Relling
Sep 2, 2008·Oncogene·R M DemarestA J Capobianco
Apr 24, 2009·The New England Journal of Medicine·Bruno C Medeiros
Jan 9, 2009·The New England Journal of Medicine·Charles G MullighanUNKNOWN Children's Oncology Group
Jun 26, 2009·The New England Journal of Medicine·Ching-Hon PuiMary V Relling
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Aug 1, 2012·Human Molecular Genetics·Gabriele StoccoWilliam E Evans
Oct 4, 2005·The Cancer Journal·Charles G MullighanJames R Downing
Sep 29, 2006·Journal of Pediatric Hematology/oncology·Jacques BaillargeonBrad H Pollock
Jun 14, 2012·Current Opinion in Oncology·Jennifer L McNeer, Elizabeth A Raetz
May 23, 2008·Pharmacogenetics and Genomics·Landry K KamdemMary V Relling
Jun 8, 2010·The Pediatric Infectious Disease Journal·Zhi-Yong KeXue-Qun Luo
Oct 6, 2009·Journal of Pediatric Hematology/oncology·Suporn TreepongkarunaSuradej Hongeng
Dec 4, 2009·Journal of Pediatric Hematology/oncology·Holly L SprakerScott C Howard
May 21, 2010·Journal of Pediatric Hematology/oncology·Pacharapan SurapolchaiNongnuch Sirachainan
Mar 26, 2011·Journal of Pediatric Hematology/oncology·Ester Augusta Lima Vinhas MarquesNorma Lucena-Silva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.